Abramov A., Schorr S., Wolman M.Generalized xanthomatosis with calcified adrenals. Am JDis Child. 1956;91:282-286.
2.
Wolman M., Sterk W., Gatt S., Frenkel M.Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant. Pediatrics. 1961;28:742-757.
3.
Crocker AC, Vawter GF, Neuhauser Ebd, RosowskyA. Wolman's disease: three new patients with a recently described lipidosis. Pediatrics. 1965;35:627-639.
Wolf A., Nolte K., Nolte R.Wolman-Syndrom. Mschr Kinderheilk.1973 ;121:697-698.
6.
Lajo A., Gracia R., Navarro M., et al. Enfermedad de Wolman en su forma aguda infantil. An Esp Pediat.1974;7:438-446.
7.
Bona G., Bracco G., Gallina MR, et al. A case of lipase deficiency: Wolman's disease. Panminerva Med.1989 ;31:49-53.
8.
Röytta M., Fagerlund AS, Toukkanen S., et al. Wolman's disease: morphological, clinical and genetic studies in the first Scandinavian cases. Clin Genet.1992; 42:1-7.
9.
Konno T., Fujii M., Watanuki T., Koizumi K.Wolman's disease: the first case in Japan. Tohoku J Exp Med.1966;90:375-398.
10.
Ho Fcs, Lin HJ, Chan WCWolman's disease: the first reported Chinese patient. Modern Med Asia.1978;14:23-26.
11.
Ellis JE, Patrick D.Wolman's disease in a Pakistani infant. Am J Dis Child.1976;130:545-547.
12.
Lowden JA, Barson AJ, Wentworth P., Obst D.Wolman's disease: a microscopic and biochemical study showing accumulation of ceroid and esterified cholesterol. Can Med Assoc J.1970;102: 402-404.
13.
Raafat F., Hashemian MP, Abrishami MAWolman's disease: report of two new cases, with a review of the literature . Am J Clin Pathol.1973;59:490-497.
14.
Kamalian N. , Dudley Jr AW, Beroukhim F. Wolman's disease with jaundice and subarachnoid hemorrhage. Am J Dis Child.1973;126:671-675.
15.
Marosvazi I.Wolman's disease in twins. Acta Paediatr Hung. 1985;26:61-64.
16.
Mahdi AH, al Mashhadani SA, al Nasser M.Wolman's disease in a Jordanian infant. Ann Trop Paediatr.1991;11:305-308.
17.
Miller R., Bialer MG, Rogers F., et al. Wolman's disease: report of a case with multiple studies. Arch Pathol Lab Med.1982;106:41-45.
18.
Ozmen MN, Aygun N., Kilic I., et al. Wolman's disease: ultrasonographic and computed tomographic findings. Pediatr Radiol.1992;22:541-542.
19.
Patrick AD, Lake BDDeficiency in acid lipase in Wolman's disease. Nature. 1969;222:1067-1068.
20.
Lin HJ, Ho Fcs, Yu Ecl, Pang SWHeterogeneity of tissue sterols and glycerolipids in Wolman's disease. Biochem Med.1985;33:342-349.
21.
Hoeg JM, Demosky Jr SJ, Brewer Jr HB. Characterization of neutral and acid ester hydrolase in Wolman's disease. Biochim Biophys Acta. 1982;711:59-65.
22.
Khoo JC, Mahoney EM, Steinberg D.Neutral cholesterol esterase activity in macrophages and its enhancement by cAMP-dependent protein kinase. J Biol Chem.1981;256:12659-12661.
23.
Coleman RA, Haynes EBDifferentiation of microsomal from lysosomal triacylglycerol activities in rat liver. Biochim Biophys Acta. 1983;751:230-240.
24.
Messieh S., ClarkeJTR, Cook HW, Spence MW. Abnormal neutral lipase activity in acid-lipase-deficient cultured human fibroblasts. Pediatr Res.1983 ;17:770-774.
25.
Burton BK, Emery D., Mueller HWLysosomal acid lipase in cultivated fibroblasts: characterization of enzyme activity in normal and enzymatically deficient cell lines. Clin Chim Acta. 1980;101:25-32.
26.
Maehira F., Nakada F., Hokama T.Characteristics of acid esterase in Wolman's disease. Biochem Med.1984;32:322-330.
27.
Werb Z., Cohn ZACholesterol metabolism in the macrophage III. Ingestion and intracellular fate of cholesterol and cholesterol ester. J Exp Med.1972;135: 21-44.
28.
Brown MS, Goldstein JLReceptor-mediated control of cholesterol metabolism. Science . 1976;191:150-154.
29.
Hoeg JM, Demosky Jr SJ, Pescovitz OH, Brewer Jr HB. Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. Am J Hum Genet. 1984 ;36:1190-1203.
30.
Salvayre R. , Negre A., Maret A., et al. Extracellular origin of the lipid lysosomal storage in cultured fibroblasts from Wolman's disease. Eur J Biochem.1987;170:453-458.
31.
Coates PM, Cortner JA, Mennuti MT, Wheeler JEPrenatal diagnosis of Wolman disease. Am J Med Genet. 1978;2:397-407.
Wolman M.Involvement of nervous tissue in primary familial xanthomatosis with adrenal calcification. Pathol Europ.1968;3:259-265.
36.
Kamoshita S. , Landing BHDistribution of lesions in myenteric plexus and gastrointestinal mucosa in lipidoses and other neurologic disorders of children. Am J Clin Pathol.1968;49:312-318.
37.
Kahana D., Berant M., Wolman M.Primary familial xanthomatosis with adrenal involvement (Wolman's disease). Report of a further case with nervous system involvement and pathogenetic consideration. Pediatrics. 1968;42:70-76.
38.
Kikuchi M., Igarashi K., Noro T., et al. Evaluation of jejunal function in Wolman's disease. J Pediatr Gastroenterol Nutr.1991;12:65-69.
39.
Bisgaier CL , Glickman RMIntestinal synthesis, secretion and transport of lipoproteins. Ann Rev Physiol.1983;45: 625-636.
40.
Sabesin SM, Frase S.Electron microscopic studies of the assembly, intracellular transport and secretion of chylomicrons by rat intestine. JLip Res.1977;18:496-511.
41.
Rao RH, Mansbach II M. Acid lipase in rat intestinal mucosa: physiological parameters . Biochim Biophys Acta. 1990;1043:273-280.
42.
Schaub J., Janka GE, Christomanou H., et al. Wolman's disease: clinical, biochemical and ultrastructural studies in an unusual case without striking adrenal calcification. Eur J Pediatr.1980 ;135:45-54.
43.
Nishikawa T. , Mikami K., Saito Y., et al. Studies on cholesterol esterase in the rat adrenal. Endocrinology.1981 ;18:932-936.
44.
Crocker AC, Fisher JN, Filler RMNutritional support, including intravenous alimentation, for the infant with Wolman's disease. In: Volk BW, Aronson SM, eds. Sphingolipids, Sphingolipidoses and Allied Disorders. New York, NY: Plenum Press; 1972:661-670.
45.
Meyers WF, Hoeg JM, Demosky SJ, et al. The use of parenteral hyperalimentation and elemental formula feeding in the treatment of Wolman disease. Nutr Res.1985;5:423-429.
46.
Kyriakides EC, Paul B., Balint JALipid accumulation and acid lipase deficiency in fibroblasts from a family with Wolman's disease, and their apparent correction in vitro. J Lab Clin Med.1972;80:810-816.
47.
Brown MS, Sobhani MK, Brunschede GY, Goldstein JLRestoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. J Biol Chem.1976 ;251:3277-3286.
48.
Sando GN, Henke VLRecognition and receptor-mediated endocytosis of the lysosomal acid lipase secreted by human fibroblasts. J Lip Res.1982;23:114-123.
49.
Ginsberg HN , Le N-A., Short MP, et al. Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. J Clin Invest.1987;80:1692-1697.
50.
Tarantino MD , McNamara DJ, Granstrom P., et al. Lovastatin therapy for cholesterol ester storage disease in two sisters. J Pediatr.1991;118:131-135.
51.
Glueck CJ, Lichtenstein P., Tracy T., Speirs J.Safety and efficacy of treatment of pediatric cholesteryl ester storage disease with lovastatin. Pediatr Res.1992 ;32:559-565.
52.
Di Bisceglie AM, Ishak KG, Rabin L., Hoeg JMCholesteryl ester storage disease: hepatopathology and effects of therapy with lovastatin. Hepatology.1990;11:764-772.
53.
Leone L., Ippoliti PEUse of simvastatin plus cholestyramine in the treatment of lysosomal acid lipase deficiency. J Pediatr.1991;119:1008-1009.
54.
Krivit W., Freese D., Chan KW, Kulkarni R.Wolman's disease: a review of treatment with bone marrow transplantation and considerations for the future. Bone Marrow Transplant.1992; (Suppl) 1:97-101.
55.
Wolman M.Proposed treatment for infants with Wolman disease. Pediatrics . 1989;83:1074-1075.
56.
Farquharson J., Cockburn F., Patrick WA, et al. Effect of diet on infant subcutaneous tissue triglyceride fatty acids. Arch Dis Child.1993;69:589-593.
57.
von Hodenberg E., Khoo JC, Jensen D., et al. Mobilization of stored triglycerides from macrophages as free fatty acids. Arteriosclerosis.1984;4:630-635.
58.
Press M., Hartop PJ, Prottey C.Correction of essential fatty-acid deficiency in man by the cutaneous application of sunflower-seed oil. Lancet. 1974 ;1:597-599.
59.
Friedman Z. , Shochat SJ, Maisels MJ, et al. Correction of fatty acid deficiency in newborn infants by cutaneous application of sunflower-seed oil. Pediatrics. 1976;58:650-654.
60.
Hunt CE, Engel RR, Modler S., et al. Essential fatty acid deficiency in neonates: inability to reverse deficiency by topical applications of EFA-rich oil. J Pediatr.1978;92:603-607.
61.
Lee EJ, Gibson RA, Simmer K.Transcutaneous application of oil and prevention of essential fatty acid deficiency in preterm infants. Arch Dis Child.1993; 68:27-28.
62.
Friedman Z.Inunction of oil to correct fatty acid deficiency. Letter to the Editor and reply by Hunt CE, Engel RR, Holman RT. J Pediatr.1978;93:1068-1069.
63.
Innis SMn-3 fatty acid requirements of the newborn. Lipids.1992 ;27:879-885.
64.
Kondoh H., Kanoh H., Ono T.Deacylation of ceramide, triacylglycerol and phospholipids in guinea pig epidermal cells. Biochim Biophys Acta. 1983; 753:97-106.
65.
Nugteren DH , Christ-Hazelhof E., van der Beek A., Houtsmuller Umt.Metabolism of linoleic acid and other essential fatty acids in the epidermis of the rat. Biochim Biophys Acta.1985 ;834:429-436.
66.
Wertz PW, Downing DTMetabolism of linoleic acid in porcine epidermis. JLip Res.1990;31:1839-1844.
